Keusch G T, Jacewicz M, Acheson D W, Donohue-Rolfe A, Kane A V, McCluer R H
Division of Geographic Medicine and Infectious Diseases, New England Medical Center, Boston, Massachusetts.
Infect Immun. 1995 Mar;63(3):1138-41. doi: 10.1128/iai.63.3.1138-1141.1995.
We reexamined the binding specificity of the Shiga-like toxin variant associated with porcine edema disease, SLT2e, which is reported to be more cytotoxic for Vero cells than for HeLa cells, by using receptor-deficient cells and a liposomal insertion system for purified glycolipids. We found that SLT2e preferentially uses globotetraosylceramide as a receptor but can also cause cytotoxicity by using globotriaosylceramide, the SLT2 receptor. We conclude that the differential cytotoxicity of SLT2e on HeLa and Vero cells is a function of both the receptor preference of the toxin and the specific glycolipid content of the target cells being used.
我们通过使用受体缺陷细胞和纯化糖脂的脂质体插入系统,重新研究了与猪水肿病相关的志贺样毒素变体SLT2e的结合特异性,据报道该毒素对Vero细胞的细胞毒性比对HeLa细胞更强。我们发现,SLT2e优先使用球四糖神经酰胺作为受体,但也可以通过使用球三糖神经酰胺(SLT2受体)引起细胞毒性。我们得出结论,SLT2e对HeLa细胞和Vero细胞的不同细胞毒性是毒素受体偏好和所用靶细胞特定糖脂含量共同作用的结果。